The shares of Comerica Incorporated (NYSE:CMA) has been pegged with a rating of Neutral by UBS in its latest research note that was published on August 5th, 2019. The research company has also assigned a $73 price target. UBS wasn’t the only research firm that published a report of Comerica Incorporated, with other equities research analysts also giving their opinion on the stock. Evercore ISI advised investors in its research note published on July 18th, 2019, to In-line the CMA stock. The stock had earned Sell rating from Citigroup when it published its report on July 12th, 2019. That day the Citigroup set price target on the stock to $66. The stock was given Underperform rating by BofA/Merrill in its report released on July 11th, 2019, the day when the price target on the stock was placed at $71. Raymond James was of a view that CMA is Mkt Perform in its latest report on July 8th, 2019. Goldman thinks that CMA is worth Sell rating. This was contained in the firm’s report on July 2nd, 2019 in which the stock’s price target was also moved to $70.
Amongst the analysts that rated the stock, 1 have recommended investors to sell it, 15 believe it has the potential for further growth, thus rating it as Hold while 3 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $76.27. The price of the stock the last time has raised by 1.79% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 31.13.
The shares of the company added by 0.93% during the trading session on Tuesday, reaching a low of $60.75 while ending the day at $61.88. During the trading session, a total of 2.1 million shares were traded which represents a -10.72% decline from the average session volume which is 1.90M shares. CMA had ended its last session trading at 61.31. Comerica Incorporated currently has a market cap of $9.33B, while its P/E ratio stands at 7.99, while its P/E earnings growth sits at 3.31, with a beta of 1.51. Comerica Incorporated debt-to-equity ratio currently stands at 0.38, while its quick ratio hovers at . CMA 52-week low price stands at $60.79 while its 52-week high price is $100.64.
The company in its last quarterly report recorded $1.94 earnings per share which is below the $2.00 predicted by most analysts. The Comerica Incorporated generated $853.00 million in revenue during the last quarter, which is slightly lower than the $858.90 million predicted by analysts. In the second quarter last year, the firm recorded $2.11 earnings per share. Compared to the same quarter last year, the firm’s revenue was down by -8.76%. Comerica Incorporated has the potential to record 7.74 EPS for the current fiscal year, according to equities analysts.
Investment analysts at Cantor Fitzgerald published a research note on June 28th, 2019 where it informed investors and clients that StoneCo Ltd. (NASDAQ:STNE) is now rated as Overweight. Evercore ISI also rated STNE as Downgrade on July 18th, 2019, with its price target of $5 suggesting that STNE could down by -5.41% from its current share price. Even though the stock has been trading at $34.26/share, analysts expect it to surge higher by 1.87% to reach $33.11/share. It started the day trading at $35.30 and traded between $33.51 and $34.90 throughout the trading session.
The stock has a high of $45.62 for the year while the low is $16.14. The company’s P/E ratio currently sits at 57.69, while the P/B ratio is 7.20. At the moment, only of StoneCo Ltd. shares were sold short. The company’s average trading volume currently stands at 2.42M shares, which means that the short-interest ratio is just 4.98 days. Over the past seven days, the company moved, with its shift of -1.97%. Looking further, the stock has raised 31.55% over the past 90 days while it gained 62.93% over the last six months.
The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. T Rowe Price Associates Inc bought more STNE shares, increasing its portfolio by +10.56% during the last quarter. This move now sees T Rowe Price Associates Inc purchasing 3,050,969 shares in the last quarter, thus it now holds 31,934,197 shares of STNE, with a total valuation of $1,118,016,237. Capital Research Management Co followed the path by decreasing its STNE portfolio by -0.33% in the quarter. This means that Capital Research Management Co sold -19,252 shares in the last quarter and now controls 5,788,318 shares of the STNE stock, with the valuation hitting $202,649,013.
Similarly, Steadfast Capital Management LP decreased its StoneCo Ltd. shares by -0.06% during the recently filed quarter. After selling -2,800 shares in the last quarter, the firm now controls 4,368,974 shares of StoneCo Ltd. which are valued at $152,957,780. In the same vein, Discovery Capital Management LLC decreased its StoneCo Ltd. shares by during the most recent reported quarter. The firm sold -101,000 shares during the quarter which decreased its stakes to 3,945,761 shares and is now valued at $138,141,093. Following these latest developments, around 26.68% of StoneCo Ltd. stocks are owned by institutional investors and hedge funds.